Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Lake Street Advisors Group LLC

Lake Street Advisors Group LLC raised its stake in Hims & Hers Health, Inc. (NYSE:HIMS) by 42.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,366 shares of the company’s stock after purchasing an additional 20,000 shares during the period. Lake Street Advisors Group LLC’s holdings in Hims & Hers Health were worth $1,241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. CWM LLC raised its position in shares of Hims & Hers Health by 21.4% during the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock worth $110,000 after acquiring an additional 1,054 shares in the last quarter. Arizona State Retirement System raised its position in shares of Hims & Hers Health by 3.0% during the 2nd quarter. Arizona State Retirement System now owns 40,344 shares of the company’s stock worth $815,000 after acquiring an additional 1,173 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Hims & Hers Health by 6.6% during the 2nd quarter. Victory Capital Management Inc. now owns 19,469 shares of the company’s stock worth $393,000 after acquiring an additional 1,212 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Hims & Hers Health by 679.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock worth $37,000 after acquiring an additional 1,603 shares in the last quarter. Finally, Swiss National Bank raised its position in shares of Hims & Hers Health by 0.7% during the 1st quarter. Swiss National Bank now owns 281,500 shares of the company’s stock worth $4,355,000 after acquiring an additional 2,000 shares in the last quarter. Institutional investors and hedge funds own 63.52% of the company’s stock.

Hims & Hers Health Stock Up 1.0 %

HIMS opened at $21.73 on Friday. The firm has a market cap of $4.67 billion, a PE ratio of 271.66 and a beta of 1.06. The business has a fifty day simple moving average of $17.59 and a 200-day simple moving average of $17.83. Hims & Hers Health, Inc. has a fifty-two week low of $5.65 and a fifty-two week high of $25.74.

Hims & Hers Health (NYSE:HIMS) last issued its earnings results on Monday, August 5th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The business had revenue of $315.65 million during the quarter, compared to analysts’ expectations of $302.43 million. Hims & Hers Health had a return on equity of 5.25% and a net margin of 1.70%. Hims & Hers Health’s revenue was up 51.8% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.03) earnings per share. On average, equities research analysts anticipate that Hims & Hers Health, Inc. will post 0.22 EPS for the current fiscal year.

Insider Buying and Selling at Hims & Hers Health

In other news, insider Michael Chi sold 7,500 shares of Hims & Hers Health stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $22.20, for a total value of $166,500.00. Following the transaction, the insider now directly owns 193,980 shares in the company, valued at approximately $4,306,356. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Andrew Dudum sold 188,888 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $16.47, for a total value of $3,110,985.36. Following the completion of the transaction, the chief executive officer now owns 33,502 shares in the company, valued at $551,777.94. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Michael Chi sold 7,500 shares of the business’s stock in a transaction that occurred on Monday, October 21st. The stock was sold at an average price of $22.20, for a total transaction of $166,500.00. Following the completion of the transaction, the insider now owns 193,980 shares of the company’s stock, valued at $4,306,356. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 841,076 shares of company stock worth $14,759,219 over the last three months. Corporate insiders own 17.71% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Imperial Capital downgraded Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research note on Friday, August 9th. Truist Financial lifted their price objective on Hims & Hers Health from $13.00 to $23.00 and gave the company a “hold” rating in a research report on Thursday, July 18th. Piper Sandler reaffirmed a “neutral” rating and issued a $18.00 target price on shares of Hims & Hers Health in a research report on Tuesday, August 6th. Bank of America increased their price target on Hims & Hers Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research report on Monday, October 21st. Finally, Needham & Company LLC assumed coverage on Hims & Hers Health in a report on Thursday, August 22nd. They issued a “buy” rating and a $24.00 price target on the stock. Eight analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, Hims & Hers Health has a consensus rating of “Moderate Buy” and a consensus target price of $20.21.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.